- Home
- RGS vs RLMD Comparison
RGS vs RLMD Comparison
Compare RGS & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- RLMD
- Stock Information
- Founded
- RGS 1922
- RLMD 2004
- Country
- RGS United States
- RLMD United States
- Employees
- RGS N/A
- RLMD N/A
- Industry
- RGS Other Consumer Services
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- RLMD Health Care
- Exchange
- RGS Nasdaq
- RLMD Nasdaq
- Market Cap
- RGS 70.8M
- RLMD 67.7M
- IPO Year
- RGS 1991
- RLMD N/A
- Fundamental
- Price
- RGS $29.50
- RLMD $2.07
- Analyst Decision
- RGS
- RLMD Hold
- Analyst Count
- RGS 0
- RLMD 2
- Target Price
- RGS N/A
- RLMD $1.00
- AVG Volume (30 Days)
- RGS 11.9K
- RLMD 352.4K
- Earning Date
- RGS 11-12-2025
- RLMD 11-06-2025
- Dividend Yield
- RGS N/A
- RLMD N/A
- EPS Growth
- RGS 20.23
- RLMD N/A
- EPS
- RGS 46.10
- RLMD N/A
- Revenue
- RGS $210,134,000.00
- RLMD N/A
- Revenue This Year
- RGS N/A
- RLMD N/A
- Revenue Next Year
- RGS N/A
- RLMD N/A
- P/E Ratio
- RGS $0.70
- RLMD N/A
- Revenue Growth
- RGS 3.52
- RLMD N/A
- 52 Week Low
- RGS $15.00
- RLMD $0.24
- 52 Week High
- RGS $31.50
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- RGS 55.18
- RLMD 55.89
- Support Level
- RGS $29.33
- RLMD $1.80
- Resistance Level
- RGS $30.50
- RLMD $2.27
- Average True Range (ATR)
- RGS 0.93
- RLMD 0.27
- MACD
- RGS -0.24
- RLMD -0.04
- Stochastic Oscillator
- RGS 35.21
- RLMD 25.73
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.